CLINICAL_TRIALS
trial_result
· 2020-01-31
Clinical Trial Update: Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients [Phase 3]
Summary
Phase 3 trial update on belimumab regarding treatment holiday and re-start in systemic lupus erythematosus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Systemic Lupus Erythematosus | Phase 3 | Status: COMPLETED | Results posted: 2020-01-31